The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Lin Yi, Andrea B. Maier, Rongsheng Tao et al. · GeroScience · 2022 · Randomised trial
Full textCC BY